Mammography Workstation Market Size, Share & Trends Analysis Report By Modality Types (Multimodal, Standalone), By Application (Diagnostic Screening, Advance Imaging), By End Use, By Region, And Segment Forecasts, 2025 - 2030

Mammography Workstation Market Trends

The global mammography workstation market size was valued at USD 33.7 million in 2024 and is expected to grow at a CAGR of 7.2% from 2025 to 2030. This growth is attributed to the rising incidence of breast cancer and growing awareness about the importance of early detection are major contributors, prompting increased adoption of advanced diagnostic technologies.

In addition, technological advancements, including integration of artificial intelligence and improved imaging solutions, are enhancing diagnostic accuracy and workflow efficiency. Furthermore, higher healthcare spending, government initiatives for breast cancer screening, and frequent product innovations by leading manufacturers are further accelerating market expansion worldwide.

A mammography workstation is a specialized digital platform used by radiologists and healthcare professionals to interpret, analyze, and manage mammographic images, primarily for the detection and diagnosis of breast cancer. The global mammography workstation market is experiencing robust growth, propelled by several interconnected factors.

As more people are diagnosed each year, the demand for advanced diagnostic solutions becomes increasingly urgent. According to the WHO breast cancer fact sheet, in 2022, 2.3 million women globally were diagnosed with breast cancer, making it the most common cancer in women in 157 out of 185 countries, with 670,000 deaths recorded that year.

The market also benefits from the frequent introduction of new and innovative products and swift regulatory approvals that quickly bring the latest technologies to healthcare providers. These advancements often result in minimally invasive procedures, enhancing patient comfort and clinical outcomes. Significant investments in research and development are fostering the creation of next-generation technologies that allow for earlier and more accurate diagnosis, empowering patients and clinicians to make informed decisions. Furthermore, rising healthcare spending, higher disposable incomes, and improvements in healthcare infrastructure are making advanced mammography solutions more accessible across different regions. Government incentives and supportive policies further encourage the adoption of cutting-edge diagnostic tools. Integrating artificial intelligence and machine learning into mammography workstations revolutionizes image analysis, increases efficiency, and opens new opportunities for market participants. For instance, as per an article published on National Library of Medicine in March 2025, between 2021 and 2023, integrating AI into mammography workstations increased the area under the curve (AUC) by 24.7% (from 0.73 to 0.91), accuracy by 15.6% (from 0.77 to 0.89), and sensitivity by 37.1% (from 0.62 to 0.85).

Moreover, expanding government screening programs, increased public awareness about breast health, and a growing elderly population are further fueling market expansion. As healthcare systems prioritize early detection and digital transformation, mammography workstations are reaching more remote and underserved communities, ensuring broader access to quality breast imaging.

Modality Types Insights

The multimodal segment led the market and held the largest revenue share of 55.3% in 2024, primarily driven by the rapid adoption of multimodal workstations in hospitals and breast care centers. These workstations offer advantages such as higher-quality patient care and enhanced radiological performance. In addition, these workstations enable the integration of images from multiple modalities, including 2D, 3D, and tomosynthesis, allowing clinicians to compare and analyze diverse imaging data efficiently. Furthermore, emerging advanced features like high-resolution displays and flexible reading protocols further boost their adoption.

The standalone segment is expected to grow at a CAGR of 10.4% over the forecast period, owing to its autonomy, user-friendly design, and specialized functionality that streamlines complex diagnostic processes for radiologists. These workstations integrate data from various modalities and vendors in one location, simplifying workflow and saving time. In addition, features such as automatic alignment of breast tissue images, graphical patient history timelines, and the ability to display digital and computed radiography enhance diagnostic accuracy and efficiency, making standalone workstations highly attractive for healthcare providers seeking dedicated, independent solutions.

Application Insights

The diagnosis screening dominated the global mammography workstation market with the largest revenue share of 39.2% in 2024. This growth is attributed to government-mandated breast screening programs, increasing public awareness, and the need for early detection of breast cancer. In addition, these factors have led to widespread adoption of mammography workstations in hospitals and diagnostic centers, ensuring efficient and accurate screening processes. Furthermore, integrating advanced imaging software and digital technologies further enhances diagnostic accuracy, supporting large-scale screening initiatives and improving patient outcomes through the timely identification of abnormalities. Furthermore, an increasing number of breast screening programs is boosting market growth. For instance, BreastScreen Australia is a national breast cancer screening program that invites women aged 50 years or older for a free mammography every two years.

The advance imaging segment is expected to grow at a CAGR of 7.4% over the forecast period, driven by high adoption of innovative imaging technologies and frequent product launches that offer enhanced visualization and interpretation capabilities. Furthermore, advanced imaging workstations support modalities such as 3D mammography and contrast-enhanced imaging, enabling radiologists to detect subtle lesions and complex cases more effectively. In 2024, an estimated 310,720 new invasive breast cancer cases and 56,500 cases of ductal carcinoma in situ were diagnosed among women in the U.S.

End Use Insights

Hospital segment held the dominant position in the market and accounted for the largest revenue share of 46.7% in 2024, driven by the increasing number of breast cancer screenings, advancements in mammography technology, and rising healthcare expenditures. Moreover, increasing healthcare funding and various government reforms are also driving the segment's growth. Many OECD countries have adopted a breast cancer screening program using tools such as a mammography workstation. Thus, the factors above are contributing to segment growth.

The clinic segment is expected to grow at a CAGR of 7.1% from 2025 to 2030, expanding due to the growing demand for accessible and specialized breast imaging services in community and outpatient settings. Clinics are increasingly adopting advanced mammography workstations to offer high-quality, efficient diagnostic services closer to patients. Furthermore, rising awareness about breast health, greater patient preference for convenient care, and improvements in clinic infrastructure contribute to this growth. Moreover, clinics often serve as the first point of contact for screening and early diagnosis, driving the need for reliable and user-friendly mammography solutions.

Regional Insights

North America's mammography workstation market dominated the global market with the largest revenue share of 60.9% in 2024. This growth is attributed to the region’s high prevalence of breast cancer and a rapidly aging population. In addition, leading industry players and robust healthcare infrastructure support the swift adoption of new solutions. Furthermore, ongoing research and development, rapid regulatory approvals, and increasing healthcare awareness fuel market growth, while cloud-based technologies and digital transformation initiatives streamline workflow and improve access to advanced diagnostic tools.

U.S. Mammography Workstation Market Trends

The mammography workstation market in the U.S. led the North American market. It accounted for the largest revenue share in 2024, driven by a strong focus on early breast cancer detection, high rates of screening, and substantial investments in healthcare technology. In addition, the country benefits from widespread insurance coverage, government-funded awareness campaigns, and a high level of public engagement in preventive health.

Asia Pacific Mammography Workstation Market Trends

The Asia Pacific mammography workstation market is expected to grow at the fastest CAGR of 7.8% over the forecast period, owing to the rising awareness about breast cancer, expanding government-sponsored screening programs, and increasing disposable incomes. Furthermore, the region’s growing elderly population and improving insurance coverage boost demand. In Asia Pacific, the number of older persons is projected to increase from 630 million in 2020 to about 1.3 billion by 2050. By 2050, one quarter of the population will be 60 or older.

The mammography workstation market in China dominated the Asia Pacific market. It held the largest revenue share in 2024, attributed to strong government support for cancer screening programs, significant investments in healthcare infrastructure, and a rising number of breast cancer cases. Furthermore, the country is rapidly transitioning from analog to digital mammography, improving diagnostic efficiency and accuracy.

Europe Mammography Workstation Market Trends

The European mammography workstation market is expected to grow significantly over the forecast period, driven by the implementation of national breast cancer screening programs, high healthcare spending, and the adoption of advanced imaging technologies. In addition, the region benefits from strong regulatory frameworks that ensure quality and safety in diagnostic procedures. Collaborative efforts between governments, research institutions, and industry players foster innovation and the introduction of next-generation mammography workstations.

Key Mammography Workstation Company Insights

Key players in the global mammography workstation market include Siemens, Analogic Corporation, and others. These companies employ strategies focused on technological innovation, expanding product portfolios, and enhancing workflow efficiency. Furthermore, they prioritize partnerships, mergers, and collaborations to strengthen market presence, target emerging markets, and invest in research and development to address evolving diagnostic and regulatory requirements.

• Siemens manufactures advanced imaging equipment, including digital mammography machines, tomosynthesis systems, and specialized workstations to enhance workflow and diagnostic accuracy. Siemens addresses various clinical requirements, offering solutions for breast cancer detection, stereotactic biopsy, and 3D imaging. Its portfolio supports hospitals and imaging centers, focusing on integrating high-performance technology across the medical imaging segment.

• Hologic, Inc. develops solutions that facilitate efficient image acquisition, manipulation, and interpretation for 2D and 3D mammography, breast MRI, and ultrasound. Its product range includes diagnostic and screening workstations, biopsy systems, and advanced image analysis software. The company primarily operates in the women’s health and breast imaging segment, serving radiologists, clinics, and hospitals with innovative diagnostic tools.

Recent Developments

• In May 2025, Hologic announced that the Genius AI Detection PRO solution was named as “Best New Imaging Technology Solution” by MedTech Breakthrough.

• In March 2024, iCAD, Inc. announced an advanced and new workstation features  for ProFound Detection. The new features are for 2D and 3D mammography that will facilitate and improve mammograms interpretation of radiologists within their workstation.

• In June 2024, FUJIFILM India Healthcare Division and NM Medical Mumbai launched the first Fujifilm skill lab. It has been launched for full-field digital mammography, and the partnership is expected to equip medical professionals with skills that can revolutionize mammography practice.

• In April 2024, Bayer and Hologic collaborated to deliver contrast-enhanced mammography (CEM) solutions. The MEDRAD Stellant FLEX CT Injection System with Certegra Workstation was the first computed tomography injection system 510(k) approved with an additional contrast-enhanced mammography (CEM) application.

Mammography Workstation Market Report Scope

Global Mammography Workstation Market Report Segmentation

This report forecasts revenue growth at global, regional and country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global mammography workstation market report based on modality types, application, end use, and region:

• Modality Types Outlook (Revenue, USD Million, 2018 - 2030)

  • Multimodal

  • Standalone

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Diagnosis Screening

  • Advance Imaging

  • Clinical Review

  • Hair Samples

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Clinics

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Norway

    • Sweden

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait